Company Profile
Acurx Pharmaceuticals Stock Price, News & Analysis
- Ticker:
- ACXP
- Exchange:
- NASDAQ
- Sector:
- Biopharma
- Location:
- United States
Stock performance
1.46 USD (-0.68%)
Close
Last updated: August 6, 2026
7.74M USD
Market cap
Why the stock is moving
As of Aug 6, 2026, ACXP closed down 0.68% at $1.46. No new same-company headline was identified in the current news window.
Company overview
Business overview
Acurx Pharmaceuticals is an anti-infective company focused on novel antibiotics for bacterial infections. Its platform is aimed at addressing antibiotic resistance in difficult pathogens.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NASDAQ, Acurx sits in specialty biopharma.
Business Model Characteristics
The company depends on clinical data, anti-infective differentiation, and the commercial opportunity in resistant infections.
Position Within the Biotechnology Landscape
Acurx is a niche anti-infective name whose valuation depends on regulatory and development progress.
Future catalysts
Acurx’s catalysts are ibezapolstat and the recurrent C. difficile program, along with any regulatory or development step that keeps the oral-antibiotic story moving. The company remains highly dependent on clinical progress.
Recent news
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Acurx Pharmaceuticals (ACXP)?
Acurx Pharmaceuticals (ACXP) most recently closed at 1.46 USD, a -0.68% move versus the previous session.
What is the market cap of Acurx Pharmaceuticals (ACXP)?
Acurx Pharmaceuticals currently has a market capitalization of 7.74M USD on BioPharmSignal.
What does Acurx Pharmaceuticals do?
Acurx Pharmaceuticals is an anti-infective company focused on novel antibiotics for bacterial infections. Its platform is aimed at addressing antibiotic resistance in difficult pathogens.
On which exchange is ACXP stock listed?
Acurx Pharmaceuticals (ACXP) is associated with NASDAQ, United States, Biopharma.
What is ibezapolstat?
Acurx’s catalysts are ibezapolstat and the recurrent C.
Which conditions is Acurx Pharmaceuticals targeting with ibezapolstat?
Acurx’s catalysts are ibezapolstat and the recurrent C.
How does Acurx Pharmaceuticals describe recent progress with ibezapolstat?
Acurx’s catalysts are ibezapolstat and the recurrent C.
What is Acurx?
Acurx Pharmaceuticals is an anti-infective company focused on novel antibiotics for bacterial infections.